Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Dendritic cells: a complex cellular system]

J C Gluckman1, B Canque, M Rosenzwajg

  • 1Service d'immunologie biologique, unité de biologie et thérapeutique des pathologies immunitaires et Laboratoire d'immunologie cellulaire de l'Ecole pratique des hautes études, hôpital de la Pitié-Salpêtrière, Paris, France.

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|May 13, 1998
PubMed
Summary

Generating dendritic cells (DCs) for immunotherapy requires precise culture methods. Optimizing cytokine combinations is key for efficient and safe clinical applications of these potent antigen-presenting cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis.

Journal of neurology·2023
Same author

Pregnant type 1 diabetes women with rises in C-peptide display higher levels of regulatory T cells: A pilot study.

Diabetes & metabolism·2020
Same author

Polyvalent immunoglobulins, platelet lysate and lenalidomide: cocktail for polyfunctional NK cells expansion for multiple myeloma.

Bone marrow transplantation·2016
Same author

Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.

Arthritis & rheumatology (Hoboken, N.J.)·2015
Same author

HIV infection: facts and hypotheses.

Immunology today·2014
Same author

Lymphodepletion followed by infusion of suicide gene-transduced donor lymphocytes to safely enhance their antitumor effect: a phase I/II study.

Leukemia·2014

Area of Science:

  • Immunology and cell biology
  • Hematopoiesis and cell differentiation

Context:

  • Dendritic cells (DCs) are potent antigen-presenting cells crucial for initiating immune responses.
  • Ex vivo generated DCs hold promise for cancer and viral immunotherapy.
  • Current research focuses on generating large numbers of DCs from hematopoietic progenitor cells.

Purpose:

  • To review methods for generating dendritic cells (DCs) from various progenitor cells.
  • To discuss the role of cytokines like GM-CSF, TNF-alpha, and IL-4 in DC differentiation.
  • To highlight the need for precise DC characterization and optimized culture conditions for immunotherapy.

Summary:

  • Recent advancements enable the generation of high numbers of dendritic cells (DCs) from CD34+ hematopoietic progenitor cells using specific growth factors.

Related Experiment Videos

  • Monocytes and macrophages can also differentiate into DCs, raising questions about lineage identity and differentiation pathways.
  • Understanding the varying antigen-presenting capacities of DCs at different differentiation stages is vital for safe and effective immunotherapy.

    • Impact:

    • Standardized and optimized DC generation protocols are essential for successful clinical immunotherapy.
    • Precise definition of DC subtypes and their functions will improve therapeutic outcomes.
    • This research informs the development of safer and more effective dendritic cell-based therapies.